Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Caleb Skipper"'
Publikováno v:
IDCases, Vol 19, Iss , Pp - (2020)
We describe a case of central venous catheter infection and bacteremia caused by Bosea thiooxidans, which has not been previously described in the literature. Bosea spp. is a gram-negative bacterium that has been isolated from hospital water supplies
Externí odkaz:
https://doaj.org/article/cb9a8c88ebdb4c8ab440b19087997b3f
Autor:
Rachel R. Atherton, Fiona V. Cresswell, Jayne Ellis, Caleb Skipper, Kiiza K. Tadeo, Gerald Mugumya, Vincent Wadda, David B. Meya, David R. Boulware
Publikováno v:
International Journal of Infectious Diseases, Vol 75, Iss , Pp 92-94 (2018)
In January 2017, the World Health Organisation recommended the Xpert® MTB/RIF Ultra assay (Ultra) for tuberculosis (TB) diagnosis. Ultra offers improved analytical sensitivity when compared with the initial Xpert® MTB/RIF (Xpert) assay for the dete
Externí odkaz:
https://doaj.org/article/e5df2f75d48f4d34af3ddbd3702c1431
Autor:
Mucunguzi Atukunda, Enock Kagimu, Morris K Rutakingirwa, Lillian Tugume, Laura Nsangi, Abdu Musubire, Jane Gakuru, Timothy Mugabi, Andrew Akampurira, Kenneth Ssebambulidde, John Kasibante, Jayne Ellis, Edward Mpoza, Darlisha A Williams, Ann M Fieberg, Caleb Skipper, Mahsa Abassi, Kathy Huppler Hullsiek, David Meya, David R Boulware
Publikováno v:
Open Forum Infectious Diseases. 9
Background Intravenous (IV) amphotericin B is the gold standard treatment of severe mycoses. A new orally absorbed, less-toxic formulation of amphotericin has been developed (Matinas Biopharma). We evaluated the efficacy of this novel anti-fungal age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c57d7d59d02240e8135d9b655743fa2e
https://doi.org/10.1093/ofid/ofac492.062
https://doi.org/10.1093/ofid/ofac492.062
Publikováno v:
Journal of Fungi, Vol 5, Iss 3, p 65 (2019)
Cryptococcal meningitis persists as a significant source of morbidity and mortality in persons with HIV/AIDS, particularly in sub-Saharan Africa. Despite increasing access to antiretrovirals, persons presenting with advanced HIV disease remains commo
Externí odkaz:
https://doaj.org/article/712a510c0c58406db27b9005e93bcb5f
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5c1b6fabb1976ed0f5ed07f7bbecded
https://doi.org/10.7759/cureus.22848
https://doi.org/10.7759/cureus.22848
Autor:
Supavit Chesdachai, Radha Rajasingham, Melanie R Nicol, David Meya, Felix Bongomin, Mahsa Abassi, Caleb Skipper, Richard Kwizera, Joshua Rhein, David Boulware
Publikováno v:
Open Forum Infectious Diseases
Background Fluconazole is lifesaving for the treatment and prevention of cryptococcosis; however, optimal dosing is unknown. Initial fluconazole doses of 100 mg to 2000 mg/day have been used. Prevalence of fluconazole non-susceptible Cryptococcus is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b7f86486a555e8db3f2ea81e980947
http://europepmc.org/articles/PMC6809647
http://europepmc.org/articles/PMC6809647
Autor:
Supavit Chesdachai, Nicole Engen, Joshua Rhein, Lillian Tugume, Tadeo kiiza. Kandole, Mahsa Abassi, Darlisha A Williams, Caleb Skipper, Kathy H Hullsiek, Abdu kisekka. Musubire, David Meya, David Boulware
Publikováno v:
Open Forum Infectious Diseases
Background C-reactive protein (CRP) is an acute-phase protein produced by the liver in response to systemic inflammation. CRP is a helpful surrogate biomarker widely used in various infections, particularly for following the progression and resolutio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8b71b32d8ab710c56ec7c96df133725
https://doi.org/10.1093/ofid/ofz360.1579
https://doi.org/10.1093/ofid/ofz360.1579
Autor:
Skipper, Caleb P1,2 (AUTHOR) skipp015@umn.edu, Kirumira, Paul1 (AUTHOR), Dai, Biyue3 (AUTHOR), Wele, Abduljewad3 (AUTHOR), Naluyima, Rose1 (AUTHOR), Namuli, Teopista1 (AUTHOR), Turya, Fred1 (AUTHOR), Muhumuza, Patrick4 (AUTHOR), Kibengo, Freddie4 (AUTHOR), Boulware, David R2 (AUTHOR), Meya, David B1,2 (AUTHOR), Nalintya, Elizabeth1 (AUTHOR), Rajasingham, Radha2 (AUTHOR) skipp015@umn.edu
Publikováno v:
Open Forum Infectious Diseases. Aug2024, Vol. 11 Issue 8, p1-7. 7p.
Publikováno v:
Open Forum Infectious Diseases. 2022 Supplement, Vol. 9, pS1-S936. 2220p.
Publikováno v:
Open Forum Infectious Diseases. Dec2022, Vol. 9 Issue 12, p1-7. 7p.